To describe a practical and reproducible technique for real-time augmented reality (AR)–guided microsurgery, achieved through direct linkage between the surgical microscope and neuronavigation system, applied to the resection of a deep-seated glioblastoma.
Methods
A real-time AR visualization system was implemented by connecting a surgical microscope (ZEISS KINEVO 900) with a neuronavigation platform (StealthStation S8, Medtronic). The system dynamically projected tumor boundaries and depth-sensitive trajectory lines into the operative view, providing continuous spatial guidance without the need for additional instruments. The technique was applied during subpial dissection and resection of a deeply located frontal glioblastoma extending toward the corpus callosum.
Results
Dynamic AR trajectory lines enabled precise delineation of resection margins and depth while maintaining a seamless surgical workflow. Near-total tumor removal was achieved under direct microscopic AR visualization without introducing additional mechanical intrusion such as catheter placement or stereotactic probes. Postoperative MRI confirmed safe and effective resection, and neurological function was preserved.
Conclusion
This technical note illustrates the feasibility and potential advantages of real-time microscope-linked AR guidance for deep-seated glioblastoma resection. The method is readily applicable in standard neurosurgical settings, requiring no specialized equipment or additional cost. Institutional review board approval was obtained, and written informed consent for the procedure and publication was secured.
{"title":"Real-time augmented reality trajectory lines technique for deep-seated glioblastoma: Technical note","authors":"Yoshiki Fujikawa, Shinji Kawabata, Hironori Yamada, Yuichiro Tsuji, Masahiko Wanibuchi","doi":"10.1016/j.wnsx.2025.100562","DOIUrl":"10.1016/j.wnsx.2025.100562","url":null,"abstract":"<div><h3>Objective</h3><div>To describe a practical and reproducible technique for real-time augmented reality (AR)–guided microsurgery, achieved through direct linkage between the surgical microscope and neuronavigation system, applied to the resection of a deep-seated glioblastoma.</div></div><div><h3>Methods</h3><div>A real-time AR visualization system was implemented by connecting a surgical microscope (ZEISS KINEVO 900) with a neuronavigation platform (StealthStation S8, Medtronic). The system dynamically projected tumor boundaries and depth-sensitive trajectory lines into the operative view, providing continuous spatial guidance without the need for additional instruments. The technique was applied during subpial dissection and resection of a deeply located frontal glioblastoma extending toward the corpus callosum.</div></div><div><h3>Results</h3><div>Dynamic AR trajectory lines enabled precise delineation of resection margins and depth while maintaining a seamless surgical workflow. Near-total tumor removal was achieved under direct microscopic AR visualization without introducing additional mechanical intrusion such as catheter placement or stereotactic probes. Postoperative MRI confirmed safe and effective resection, and neurological function was preserved.</div></div><div><h3>Conclusion</h3><div>This technical note illustrates the feasibility and potential advantages of real-time microscope-linked AR guidance for deep-seated glioblastoma resection. The method is readily applicable in standard neurosurgical settings, requiring no specialized equipment or additional cost. Institutional review board approval was obtained, and written informed consent for the procedure and publication was secured.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100562"},"PeriodicalIF":2.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.wnsx.2025.100558
Robert Nickl , Hannah Mais , Ghadir Abbas , Hazem Eldebakey , Jonas Roothans , Martin Reich , Cordula Matthies , Patrick Fricke
Objective
To assess the relationship between intraoperative test stimulation sites and postoperative best active contacts in STN-DBS for Parkinson's disease and to evaluate whether intraoperative VTAs predict long-term outcome.
Methods
We retrospectively analyzed 92 hemispheres in 46 patients undergoing bilateral STN-DBS. Coordinates of the best intraoperative stimulation point and the best active contact at one year postoperatively were compared using vector analysis. Corresponding VTAs were modeled and visualized in normalized MNI space using Guide XT and MATLAB-based tools. Response ratios were calculated based on motor improvement (UPDRS-III) at one year.
Results
The intraoperative and postoperative best stimulation points differed significantly (p < 0.001), with a consistent dorsolateral shift of the chronic stimulation site relative to the intraoperative test position. Group-level COG analysis showed a 1.61 mm Euclidean shift. VTA overlap between intraoperative and chronic stimulation sites was low (Dice index 0.26). Intraoperative VTAs did not predict clinical outcome. Mean motor improvement was 44 % (range 10–80 %). No significant difference in outcome was observed between patients with bilateral central trajectories and those with non-central implantations guided by intraoperative testing (p = 0.49).
Conclusion
Our findings demonstrate a systematic spatial difference between intraoperative and postoperative best active contact. Intraoperative VTAs, derived primarily from rigidity-based testing, did not predict global one-year motor improvement, underscoring the limited role of intraoperative testing as a universal predictor of long-term outcome. Imaging-based targeting achieved outcomes comparable to intraoperative test-guided implantation, supporting the feasibility of simplified, image-guided workflows in DBS planning.
{"title":"Correlation of intra- and postoperative best active contact and its implication for STN-DBS outcome","authors":"Robert Nickl , Hannah Mais , Ghadir Abbas , Hazem Eldebakey , Jonas Roothans , Martin Reich , Cordula Matthies , Patrick Fricke","doi":"10.1016/j.wnsx.2025.100558","DOIUrl":"10.1016/j.wnsx.2025.100558","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the relationship between intraoperative test stimulation sites and postoperative best active contacts in STN-DBS for Parkinson's disease and to evaluate whether intraoperative VTAs predict long-term outcome.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed 92 hemispheres in 46 patients undergoing bilateral STN-DBS. Coordinates of the best intraoperative stimulation point and the best active contact at one year postoperatively were compared using vector analysis. Corresponding VTAs were modeled and visualized in normalized MNI space using Guide XT and MATLAB-based tools. Response ratios were calculated based on motor improvement (UPDRS-III) at one year.</div></div><div><h3>Results</h3><div>The intraoperative and postoperative best stimulation points differed significantly (<em>p</em> < 0.001), with a consistent dorsolateral shift of the chronic stimulation site relative to the intraoperative test position. Group-level COG analysis showed a 1.61 mm Euclidean shift. VTA overlap between intraoperative and chronic stimulation sites was low (Dice index 0.26). Intraoperative VTAs did not predict clinical outcome. Mean motor improvement was 44 % (range 10–80 %). No significant difference in outcome was observed between patients with bilateral central trajectories and those with non-central implantations guided by intraoperative testing (<em>p</em> = 0.49).</div></div><div><h3>Conclusion</h3><div>Our findings demonstrate a systematic spatial difference between intraoperative and postoperative best active contact. Intraoperative VTAs, derived primarily from rigidity-based testing, did not predict global one-year motor improvement, underscoring the limited role of intraoperative testing as a universal predictor of long-term outcome. Imaging-based targeting achieved outcomes comparable to intraoperative test-guided implantation, supporting the feasibility of simplified, image-guided workflows in DBS planning.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100558"},"PeriodicalIF":2.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145683020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.wnsx.2025.100557
Vera Ong , Paul M. Harary , Amit R. Persad, Yusuke S. Hori, Sara C. Emrich, Louisa Ustrzynski, Armine Tayag, David J. Park, Steven D. Chang
Objective
To review the outcomes of surgery for asymmetric sensorineural hearing loss (ASHL) from neurovascular compromise of the vestibulocochlear nerve.
Methods
A systematic review was conducted using the Web of Science, Cochrane, PubMed, and PsychINFO databases. We additionally performed a retrospective review of our institution's database for cases with ASHL resulting from vascular loop-induced vestibulocochlear nerve compression.
Results
Fifteen articles were included in our literature review, representing a total of 24 patients. Of these 24 patients, 8 patients were managed conservatively, and 16 patients were managed surgically. Among the patients who underwent conservative management, 4 patients (50 %) had no reported vestibulocochlear post-treatment outcomes. One patient mentioned subjectively improved hearing, whereas the remaining patients either had no change or worsening of hearing loss. One patient reported tinnitus improvement, while another had persistent tinnitus and vertigo. Among the 16 patients who underwent surgery, 7 patients (44 %) showed improved hearing postoperatively, while 1 patient's hearing continued to deteriorate. Improvement of vertigo/disequilibrium and tinnitus was mentioned in 11 and 9 patients, respectively. Separately, our institution presented 2 patients: one treated surgically with mild hearing improvement and another managed conservatively with ongoing evaluation.
Conclusion
Indications for treatment of ASHL with associated vascular loop causing vestibulocochlear nerve compression remain unclear. Overlapping vestibulocochlear symptoms of hearing loss and pulsatile tinnitus within a patient case seem of higher surgical priority versus a patient case with worsening hearing.
目的探讨前庭耳蜗神经血管损伤引起的非对称感音神经性听力损失的手术治疗效果。方法采用Web of Science、Cochrane、PubMed和PsychINFO数据库进行系统评价。此外,我们对本院数据库中由血管袢诱导的前庭耳蜗神经压迫引起的ASHL病例进行了回顾性分析。结果我们的文献综述纳入15篇文章,共24例患者。在这24例患者中,8例患者采用保守治疗,16例患者采用手术治疗。在接受保守治疗的患者中,4例患者(50%)未报告前庭耳蜗治疗后结果。1例患者主观听力有所改善,其余患者听力没有变化或恶化。一名患者报告耳鸣改善,而另一名患者持续耳鸣和眩晕。16例手术患者中,7例(44%)患者术后听力改善,1例患者听力继续恶化。眩晕/不平衡和耳鸣的改善分别有11例和9例。另外,我们的机构报告了2例患者:1例手术治疗轻度听力改善,另1例保守治疗并进行持续评估。结论ASHL合并血管袢致前庭耳蜗神经压迫的适应证尚不明确。与听力恶化的患者相比,前庭耳蜗重叠症状的听力损失和搏动性耳鸣患者的手术优先权似乎更高。
{"title":"Management of neurovascular compromise of the vestibulocochlear nerve: A systematic review and illustrative case series","authors":"Vera Ong , Paul M. Harary , Amit R. Persad, Yusuke S. Hori, Sara C. Emrich, Louisa Ustrzynski, Armine Tayag, David J. Park, Steven D. Chang","doi":"10.1016/j.wnsx.2025.100557","DOIUrl":"10.1016/j.wnsx.2025.100557","url":null,"abstract":"<div><h3>Objective</h3><div>To review the outcomes of surgery for asymmetric sensorineural hearing loss (ASHL) from neurovascular compromise of the vestibulocochlear nerve.</div></div><div><h3>Methods</h3><div>A systematic review was conducted using the Web of Science, Cochrane, PubMed, and PsychINFO databases. We additionally performed a retrospective review of our institution's database for cases with ASHL resulting from vascular loop-induced vestibulocochlear nerve compression.</div></div><div><h3>Results</h3><div>Fifteen articles were included in our literature review, representing a total of 24 patients. Of these 24 patients, 8 patients were managed conservatively, and 16 patients were managed surgically. Among the patients who underwent conservative management, 4 patients (50 %) had no reported vestibulocochlear post-treatment outcomes. One patient mentioned subjectively improved hearing, whereas the remaining patients either had no change or worsening of hearing loss. One patient reported tinnitus improvement, while another had persistent tinnitus and vertigo. Among the 16 patients who underwent surgery, 7 patients (44 %) showed improved hearing postoperatively, while 1 patient's hearing continued to deteriorate. Improvement of vertigo/disequilibrium and tinnitus was mentioned in 11 and 9 patients, respectively. Separately, our institution presented 2 patients: one treated surgically with mild hearing improvement and another managed conservatively with ongoing evaluation.</div></div><div><h3>Conclusion</h3><div>Indications for treatment of ASHL with associated vascular loop causing vestibulocochlear nerve compression remain unclear. Overlapping vestibulocochlear symptoms of hearing loss and pulsatile tinnitus within a patient case seem of higher surgical priority versus a patient case with worsening hearing.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100557"},"PeriodicalIF":2.0,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-28DOI: 10.1016/j.wnsx.2025.100556
GuoLi Ren , ShuNing Liu , Xiao Gao , Bo Wang , Daliang Liu , XueHuan Liu , Hao Wang , Jun Liu
Background and purpose
Intracerebral hemorrhage (ICH) volume is a primary concern in acute ICH management, as timely prognostic assessment correlates with increased risk of long-term unfavorable functional outcome. This study aimed to evaluate the predictive value of the maximum hemorrhage area (sICH-MaxA) and orthogonal diameters (sICH-OD) on the slice with the largest hemorrhage area on non-contrast computed tomography (NCCT) for long-term (12-month) unfavorable functional outcome in supratentorial spontaneous intracerebral hemorrhage (sICH).
Methods
A total of 113 patients with supratentorial sICH admitted between June 2022 and June 2024 were enrolled. Patients were categorized into an unfavorable outcome group (modified Rankin Scale score >3, n = 41) and a favorable outcome group (modified Rankin Scale score ≤3, n = 72). sICH-MaxA and sICH-OD were measured on NCCT and compared with sICH volume. The efficacy of these metrics for assessing long-term unfavorable functional outcome in supratentorial sICH was evaluated.
Results
Correlation analysis revealed significant associations between sICH-MaxA, sICH-OD, and sICH volume (r = 0.957 and 0.954, respectively; p < 0.001). The thresholds of sICH-MaxA and sICH-OD for predicting long-term unfavorable outcome were ≥4.705 cm2 (p < 0.001) and ≥9.255 cm2 (p < 0.001), respectively. The thresholds for determining the need for surgical intervention were sICH-MaxA >5.56 cm2 (p < 0.001) and sICH-OD >9.85 cm2 (p < 0.001). The areas under the curve (AUC) for predicting long-term unfavorable functional outcome were: sICH volume = 0.873, sICH-MaxA = 0.866, sICH-OD = 0.855.
Conclusion
sICH-MaxA and sICH-OD measured on NCCT demonstrate predictive value for long-term unfavorable functional outcome in patients with supratentorial sICH.
{"title":"Predictive value of maximum hemorrhage area and orthogonal diameter on non-contrast CT for assessing long-term unfavorable functional outcome in intracerebral hemorrhage","authors":"GuoLi Ren , ShuNing Liu , Xiao Gao , Bo Wang , Daliang Liu , XueHuan Liu , Hao Wang , Jun Liu","doi":"10.1016/j.wnsx.2025.100556","DOIUrl":"10.1016/j.wnsx.2025.100556","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Intracerebral hemorrhage (ICH) volume is a primary concern in acute ICH management, as timely prognostic assessment correlates with increased risk of long-term unfavorable functional outcome. This study aimed to evaluate the predictive value of the maximum hemorrhage area (sICH-MaxA) and orthogonal diameters (sICH-OD) on the slice with the largest hemorrhage area on non-contrast computed tomography (NCCT) for long-term (12-month) unfavorable functional outcome in supratentorial spontaneous intracerebral hemorrhage (sICH).</div></div><div><h3>Methods</h3><div>A total of 113 patients with supratentorial sICH admitted between June 2022 and June 2024 were enrolled. Patients were categorized into an unfavorable outcome group (modified Rankin Scale score >3, <em>n</em> = 41) and a favorable outcome group (modified Rankin Scale score ≤3, <em>n</em> = 72). sICH-MaxA and sICH-OD were measured on NCCT and compared with sICH volume. The efficacy of these metrics for assessing long-term unfavorable functional outcome in supratentorial sICH was evaluated.</div></div><div><h3>Results</h3><div>Correlation analysis revealed significant associations between sICH-MaxA, sICH-OD, and sICH volume (<em>r</em> = 0.957 and 0.954, respectively; <em>p</em> < 0.001). The thresholds of sICH-MaxA and sICH-OD for predicting long-term unfavorable outcome were ≥4.705 cm<sup>2</sup> (<em>p</em> < 0.001) and ≥9.255 cm<sup>2</sup> (<em>p</em> < 0.001), respectively. The thresholds for determining the need for surgical intervention were sICH-MaxA >5.56 cm<sup>2</sup> (<em>p</em> < 0.001) and sICH-OD >9.85 cm<sup>2</sup> (<em>p</em> < 0.001). The areas under the curve (AUC) for predicting long-term unfavorable functional outcome were: sICH volume = 0.873, sICH-MaxA = 0.866, sICH-OD = 0.855.</div></div><div><h3>Conclusion</h3><div>sICH-MaxA and sICH-OD measured on NCCT demonstrate predictive value for long-term unfavorable functional outcome in patients with supratentorial sICH.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100556"},"PeriodicalIF":2.0,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145617557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-27DOI: 10.1016/j.wnsx.2025.100555
Verónica Garza-Rodríguez , Andrea Ortiz , Mariya Miteva , Hector R. Martinez , Nerea Martin del Campo , Paloma Acacia Guzman-Garcia , Beatriz Perez-Martinez , Oscar Gutierrez-Trevino , Rogelio E. Flores-Salcido , Mario Benvenutti-Regato , Jose A. Figueroa-Sanchez
Endovascular embolization is the mainstay of treatment for multiple diseases affecting the superficial temporal artery (STA). However, it is not exempt from complications. While neurologic complications are vastly reported in the literature, dermatological complications are seldom described. Here, we present the case of a 16-year-old female who developed pustules, erythema, trichodynia and regional pain along the facial branch of the STA following endovascular treatment. On trichoscopy follicular crusts with microhemorrhagic areas, erythema, telangiectasia and patchy brown-gray areas were visualized with histopathologic findings compatible with vasculopathy and increased telogen count. Additionally, we performed a literature review of dermatological complications associated with endovascular treatment of the STA. A total of 16 cases were identified, most of which involved trans-arterial embolization (TAE). The most common dermatological complication was scalp necrosis (50 %), followed by secondary infection (18.75 %) and mass effect (18.75 %). The time of presentation varied, from immediately after embolization up to 46 days post-procedure. The most common embolic agent associated with complications was Onyx (50 %). According to our review, dermatologic complications seem to arise from multiple mechanisms, including tissue inflammation, cell wall rupture, radiation damage, and infusion rate of the embolic agents. We emphasize the need for greater attention and reporting of these complications, as they can impact cosmetic outcomes and overall quality of life of patients. Physicians should be aware of cutaneous manifestations following STA embolization as early recognition and appropriate management can significantly improve cosmetic outcomes.
{"title":"Dermatological complications in superficial temporal artery embolization: An illustrative case and literature review","authors":"Verónica Garza-Rodríguez , Andrea Ortiz , Mariya Miteva , Hector R. Martinez , Nerea Martin del Campo , Paloma Acacia Guzman-Garcia , Beatriz Perez-Martinez , Oscar Gutierrez-Trevino , Rogelio E. Flores-Salcido , Mario Benvenutti-Regato , Jose A. Figueroa-Sanchez","doi":"10.1016/j.wnsx.2025.100555","DOIUrl":"10.1016/j.wnsx.2025.100555","url":null,"abstract":"<div><div>Endovascular embolization is the mainstay of treatment for multiple diseases affecting the superficial temporal artery (STA). However, it is not exempt from complications. While neurologic complications are vastly reported in the literature, dermatological complications are seldom described. Here, we present the case of a 16-year-old female who developed pustules, erythema, trichodynia and regional pain along the facial branch of the STA following endovascular treatment. On trichoscopy follicular crusts with microhemorrhagic areas, erythema, telangiectasia and patchy brown-gray areas were visualized with histopathologic findings compatible with vasculopathy and increased telogen count. Additionally, we performed a literature review of dermatological complications associated with endovascular treatment of the STA. A total of 16 cases were identified, most of which involved trans-arterial embolization (TAE). The most common dermatological complication was scalp necrosis (50 %), followed by secondary infection (18.75 %) and mass effect (18.75 %). The time of presentation varied, from immediately after embolization up to 46 days post-procedure. The most common embolic agent associated with complications was Onyx (50 %). According to our review, dermatologic complications seem to arise from multiple mechanisms, including tissue inflammation, cell wall rupture, radiation damage, and infusion rate of the embolic agents. We emphasize the need for greater attention and reporting of these complications, as they can impact cosmetic outcomes and overall quality of life of patients. Physicians should be aware of cutaneous manifestations following STA embolization as early recognition and appropriate management can significantly improve cosmetic outcomes.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100555"},"PeriodicalIF":2.0,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145683124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-26DOI: 10.1016/j.wnsx.2025.100552
Amer A. Jaradat , Mohammed M. Barbarawi , Mohammed Jamous , Sultan M. Jarrar , Suleiman S. Daoud , Amjed Abdelal , Said Haddad , Reem Alazzam , Marah Bashyreh , Owais Ghammaz
Background
Ventriculoperitoneal (VP) shunt infections, notably when caused by Acinetobacter baumannii, present significant management challenges in pediatric neurosurgery due to antibiotic resistance. This study assesses clinical profiles, microbiological characteristics, treatment strategies, and outcomes of these infections.
Methods
A retrospective review at King Abdullah University Hospital, North Jordan, analyzed 27 pediatric cases of Acinetobacter baumannii VP shunt infections from 2013 to 2023. Data on demographics, clinical presentation, treatment strategies, and outcomes, including cerebrospinal fluid (CSF) clearance time and time to shunt re-insertion, morbidity, and mortality were evaluated.
Results
Colistin showed efficacy against multidrug-resistant strains, despite overall high resistance to conventional antibiotics. Infections predominantly occurred early post-surgery and an 11.1 % mortality rate was observed.
Conclusion
VP shunt infections caused by Acinetobacter baumannii significantly impact pediatric patients, emphasizing the need for early detection and the development of targeted treatment approaches. Colistin may offer a viable option against resistant strains, but prolonged hospitalization and mortality rates call for improved preventive measures.
{"title":"Acinetobacter baumannii ventriculoperitoneal shunt infection in the pediatric population: Clinical assessment and microbiological profile","authors":"Amer A. Jaradat , Mohammed M. Barbarawi , Mohammed Jamous , Sultan M. Jarrar , Suleiman S. Daoud , Amjed Abdelal , Said Haddad , Reem Alazzam , Marah Bashyreh , Owais Ghammaz","doi":"10.1016/j.wnsx.2025.100552","DOIUrl":"10.1016/j.wnsx.2025.100552","url":null,"abstract":"<div><h3>Background</h3><div>Ventriculoperitoneal (VP) shunt infections, notably when caused by <em>Acinetobacter baumannii</em>, present significant management challenges in pediatric neurosurgery due to antibiotic resistance. This study assesses clinical profiles, microbiological characteristics, treatment strategies, and outcomes of these infections.</div></div><div><h3>Methods</h3><div>A retrospective review at King Abdullah University Hospital, North Jordan, analyzed 27 pediatric cases of <em>Acinetobacter baumannii</em> VP shunt infections from 2013 to 2023. Data on demographics, clinical presentation, treatment strategies, and outcomes, including cerebrospinal fluid (CSF) clearance time and time to shunt re-insertion, morbidity, and mortality were evaluated.</div></div><div><h3>Results</h3><div>Colistin showed efficacy against multidrug-resistant strains, despite overall high resistance to conventional antibiotics. Infections predominantly occurred early post-surgery and an 11.1 % mortality rate was observed.</div></div><div><h3>Conclusion</h3><div>VP shunt infections caused by <em>Acinetobacter baumannii</em> significantly impact pediatric patients, emphasizing the need for early detection and the development of targeted treatment approaches. Colistin may offer a viable option against resistant strains, but prolonged hospitalization and mortality rates call for improved preventive measures.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100552"},"PeriodicalIF":2.0,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145683121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1016/j.wnsx.2025.100550
Alexa R. Lauinger , Anvita Mishra , Helen Kemprecos , Kathryn Tsai , Varshal Patel , Albert Yu , Wael Hassaneen
Background
Traumatic brain injury annually affects around 69 million individuals worldwide. Penetrating traumatic brain injuries (pTBI) have a high morbidity and mortality rate. There has been an increase in the incidence of pTBI and an increase in the rate of operative intervention. However, there's still limited data on how injury details and treatment can impact patient outcomes. This project will explore the factors associated with poor outcomes following pTBI using the United States National Trauma Data Bank (NTDB).
Methods
Data from the NTDB for patients with a pTBI between 2017 and 2021 were collected. Logistic regression was completed on data from 2017 to 2018 to develop a multivariable model. This model was tested internally and externally.
Results
The multivariable regression model for in-hospital complications included the emergency department Glasgow Coma Scale (GCS), penetration greater than 2 cm, external ventricular drain (EVD) placement, Injury Severity Score (ISS), and transfusion. This model achieved an accuracy of 89.5 % and 87.1 % in internal and external testing cohorts, respectively. The model for length of stay included ISS, transfusion, and EVD placement. The complications model included EVD placement, transfusion, and ISS. The accuracy for the length of stay model was around 71 %, while it was around 93 % for the complication model.
Conclusion
As the prevalence of pTBI remains high in the US, it is vital to understand the factors associated with poor prognosis. The severity of the overall injury, patient age, and procedures were the most predictive parameters. Interestingly, the location of fractures and associated complications was not as important in this model.
{"title":"Risk factors for patient outcomes following penetrating traumatic brain injury","authors":"Alexa R. Lauinger , Anvita Mishra , Helen Kemprecos , Kathryn Tsai , Varshal Patel , Albert Yu , Wael Hassaneen","doi":"10.1016/j.wnsx.2025.100550","DOIUrl":"10.1016/j.wnsx.2025.100550","url":null,"abstract":"<div><h3>Background</h3><div>Traumatic brain injury annually affects around 69 million individuals worldwide. Penetrating traumatic brain injuries (pTBI) have a high morbidity and mortality rate. There has been an increase in the incidence of pTBI and an increase in the rate of operative intervention. However, there's still limited data on how injury details and treatment can impact patient outcomes. This project will explore the factors associated with poor outcomes following pTBI using the United States National Trauma Data Bank (NTDB).</div></div><div><h3>Methods</h3><div>Data from the NTDB for patients with a pTBI between 2017 and 2021 were collected. Logistic regression was completed on data from 2017 to 2018 to develop a multivariable model. This model was tested internally and externally.</div></div><div><h3>Results</h3><div>The multivariable regression model for in-hospital complications included the emergency department Glasgow Coma Scale (GCS), penetration greater than 2 cm, external ventricular drain (EVD) placement, Injury Severity Score (ISS), and transfusion. This model achieved an accuracy of 89.5 % and 87.1 % in internal and external testing cohorts, respectively. The model for length of stay included ISS, transfusion, and EVD placement. The complications model included EVD placement, transfusion, and ISS. The accuracy for the length of stay model was around 71 %, while it was around 93 % for the complication model.</div></div><div><h3>Conclusion</h3><div>As the prevalence of pTBI remains high in the US, it is vital to understand the factors associated with poor prognosis. The severity of the overall injury, patient age, and procedures were the most predictive parameters. Interestingly, the location of fractures and associated complications was not as important in this model.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100550"},"PeriodicalIF":2.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1016/j.wnsx.2025.100554
Ao Chen, Jianxian Li, Bin Tan, Rong Xiang, Renhui Zhou
Background
Compared to intracerebral hemorrhage (ICH) with large hemorrhage volume, early poor outcomes in mild-to-moderate hemorrhage volume ICH (MMV-ICH) remains poorly understood. We aimed to analyze risk factors in patients with MMV-ICH and establish a nomogram model to predict early poor outcomes in such cases.
Methods
We conducted a retrospective analysis of data from 681 patients with MMV-ICH treated at our hospital (May 2019–May 2024). Baseline demographic information, clinical characteristics, and outcomes were collected. Early poor outcomes were defined as in-hospital death or discharge against medical advice. Least absolute shrinkage and selection operator (LASSO) and stepwise logistic regression analyses were used to screen risk factors for early poor outcomes and construct the prediction model, respectively. The model was visualized using a nomogram; its predictive performance was compared with the original ICH score. The nomogram prediction model was internally validated using 10-fold cross-validation combined with Bootstrap resampling.
Results
Of 681 patients, 71 (10.4 %) experienced early poor outcomes during hospitalization. Univariate analysis revealed 16 risk factors. LASSO and stepwise logistic regression analyses identified four independent predictors: admission Glasgow Coma Scale (GCS) score, hematoma volume, hematoma expansion, and ventricular enlargement. The nomogram based on these factors demonstrated good calibration (mean absolute error 0.011) and superior predictive performance compared with the ICH score (area under the receiver operating characteristic curve: 0.895 vs. 0.801, p < 0.001). Decision curve analysis further demonstrated that the model had greater net benefit than the ICH score. Internal validation confirmed the model's stability and generalizability (10-fold cross-validation mean: 0.8893; bootstrap-corrected C-index: 0.8899).
Conclusions
Patients with MMV-ICH with lower admission GCS, larger hematoma, ventricular enlargement, and hematoma expansion post-admission exhibit higher risk of early poor outcomes. The nomogram incorporating these factors potentially identifies early poor outcomes during hospitalization in this population, aiding neurologists in early clinical-decision making.
背景:与大出血量脑出血(ICH)相比,轻至中度出血量脑出血(MMV-ICH)的早期不良结局仍然知之甚少。我们的目的是分析MMV-ICH患者的危险因素,并建立一个nomogram模型来预测此类病例的早期不良预后。方法回顾性分析2019年5月- 2024年5月在我院治疗的681例MMV-ICH患者的资料。收集基线人口统计信息、临床特征和结果。早期不良预后被定义为院内死亡或不遵医嘱出院。使用最小绝对收缩和选择算子(LASSO)和逐步逻辑回归分析分别筛选早期不良预后的危险因素和构建预测模型。模型采用模态图可视化;将其预测性能与原始ICH评分进行比较。采用10次交叉验证结合Bootstrap重采样对nomogram预测模型进行内部验证。结果681例患者中,71例(10.4%)在住院期间出现早期不良预后。单因素分析显示16个危险因素。LASSO和逐步逻辑回归分析确定了四个独立的预测因素:入院格拉斯哥昏迷量表(GCS)评分、血肿体积、血肿扩张和心室增大。与ICH评分(受试者工作特征曲线下面积:0.895 vs. 0.801, p < 0.001)相比,基于这些因素的nomogram显示出良好的校准(平均绝对误差0.011)和优越的预测性能。决策曲线分析进一步表明,该模型的净效益高于ICH评分。内部验证证实了模型的稳定性和可推广性(10倍交叉验证均值:0.8893;bootstrap校正的C-index: 0.8899)。结论MMV-ICH患者入院时GCS较低,入院后血肿、脑室增大、血肿扩张较大,早期预后不良的风险较高。结合这些因素的nomogram潜在地识别出该人群住院期间的早期不良预后,帮助神经科医生进行早期临床决策。
{"title":"Risk factors for early poor outcomes in intracerebral hemorrhage with mild-to-moderate volume: A retrospective cohort study","authors":"Ao Chen, Jianxian Li, Bin Tan, Rong Xiang, Renhui Zhou","doi":"10.1016/j.wnsx.2025.100554","DOIUrl":"10.1016/j.wnsx.2025.100554","url":null,"abstract":"<div><h3>Background</h3><div>Compared to intracerebral hemorrhage (ICH) with large hemorrhage volume, early poor outcomes in mild-to-moderate hemorrhage volume ICH (MMV-ICH) remains poorly understood. We aimed to analyze risk factors in patients with MMV-ICH and establish a nomogram model to predict early poor outcomes in such cases.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis of data from 681 patients with MMV-ICH treated at our hospital (May 2019–May 2024). Baseline demographic information, clinical characteristics, and outcomes were collected. Early poor outcomes were defined as in-hospital death or discharge against medical advice. Least absolute shrinkage and selection operator (LASSO) and stepwise logistic regression analyses were used to screen risk factors for early poor outcomes and construct the prediction model, respectively. The model was visualized using a nomogram; its predictive performance was compared with the original ICH score. The nomogram prediction model was internally validated using 10-fold cross-validation combined with Bootstrap resampling.</div></div><div><h3>Results</h3><div>Of 681 patients, 71 (10.4 %) experienced early poor outcomes during hospitalization. Univariate analysis revealed 16 risk factors. LASSO and stepwise logistic regression analyses identified four independent predictors: admission Glasgow Coma Scale (GCS) score, hematoma volume, hematoma expansion, and ventricular enlargement. The nomogram based on these factors demonstrated good calibration (mean absolute error 0.011) and superior predictive performance compared with the ICH score (area under the receiver operating characteristic curve: 0.895 vs. 0.801, <em>p</em> < 0.001). Decision curve analysis further demonstrated that the model had greater net benefit than the ICH score. Internal validation confirmed the model's stability and generalizability (10-fold cross-validation mean: 0.8893; bootstrap-corrected C-index: 0.8899).</div></div><div><h3>Conclusions</h3><div>Patients with MMV-ICH with lower admission GCS, larger hematoma, ventricular enlargement, and hematoma expansion post-admission exhibit higher risk of early poor outcomes. The nomogram incorporating these factors potentially identifies early poor outcomes during hospitalization in this population, aiding neurologists in early clinical-decision making.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100554"},"PeriodicalIF":2.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145683125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24DOI: 10.1016/j.wnsx.2025.100553
Giorgio Cracchiolo , Clifford Pierre , Luke L. Jouppi , Julius Gerstmeyer , Colin Gold , Mark Kraemer , Angela Kantor , Arnav Gambhir , Amir Abdul-Jabbar , Andrea Fanti , Carlo Brembilla , Rod Oskouian , Jens R. Chapman
Background
Epstein–Barr Virus (EBV) is associated with smooth muscle tumors (SMT) in immunocompromised individuals, including those with HIV or post-transplant status. EBV-related SMTs are rare in the spine, making diagnosis and treatment challenging. This study provides updated insights into their diagnosis and treatment.
Methods
A formal PubMed literature review was conducted using search terms related to EBV-SMTs with screening performed based on the JBI Critical Appraisal Criteria. We included systematic reviews, literature reviews, case series, and case reports while excluding any studies that were not related to EBV-SMTs. Included literature was analyzed for epidemiology, pathogenesis, histopathology, imaging, clinical presentation, management, and prognosis, with a focus on spinal cases.
Results
Between 1995 and 2023, 98 general articles were identified, 62 meeting our specific inclusion criteria. An updated treatment algorithm, including a multidisciplinary approach, was outlined. A pertinent clinical case of a 55-year-old HIV-positive female with multiple thoracic spine lesions and biopsy confirmation of EBV-SMT was presented. Following vertebroplasty, tumor excision, and antiretroviral therapy, she developed recurrent lesions four years later, requiring further treatment.
Conclusion
Spinal EBV-SMTs are rare CNS tumors to consider as differential diagnosis for immunocompromised patients with spine-related pain and/or neurological deficits. Neuroimaging for lesion detection followed by biopsy confirmation using specialized staining can confirm diagnosis. Multimodal treatment with efforts at optimizing immune competency, surgical resection, and emerging therapies such as mTOR inhibitors (sirolimus) and radiotherapy have been recommended. Our comprehensive review supports ongoing research efforts using multi-institutional databases to allow for enhanced scientific insights into these rare tumors.
{"title":"Spinal Epstein–Barr virus-related smooth muscle tumors: Narrative review and case study","authors":"Giorgio Cracchiolo , Clifford Pierre , Luke L. Jouppi , Julius Gerstmeyer , Colin Gold , Mark Kraemer , Angela Kantor , Arnav Gambhir , Amir Abdul-Jabbar , Andrea Fanti , Carlo Brembilla , Rod Oskouian , Jens R. Chapman","doi":"10.1016/j.wnsx.2025.100553","DOIUrl":"10.1016/j.wnsx.2025.100553","url":null,"abstract":"<div><h3>Background</h3><div>Epstein–Barr Virus (EBV) is associated with smooth muscle tumors (SMT) in immunocompromised individuals, including those with HIV or post-transplant status. EBV-related SMTs are rare in the spine, making diagnosis and treatment challenging. This study provides updated insights into their diagnosis and treatment.</div></div><div><h3>Methods</h3><div>A formal PubMed literature review was conducted using search terms related to EBV-SMTs with screening performed based on the JBI Critical Appraisal Criteria. We included systematic reviews, literature reviews, case series, and case reports while excluding any studies that were not related to EBV-SMTs. Included literature was analyzed for epidemiology, pathogenesis, histopathology, imaging, clinical presentation, management, and prognosis, with a focus on spinal cases.</div></div><div><h3>Results</h3><div>Between 1995 and 2023, 98 general articles were identified, 62 meeting our specific inclusion criteria. An updated treatment algorithm, including a multidisciplinary approach, was outlined. A pertinent clinical case of a 55-year-old HIV-positive female with multiple thoracic spine lesions and biopsy confirmation of EBV-SMT was presented. Following vertebroplasty, tumor excision, and antiretroviral therapy, she developed recurrent lesions four years later, requiring further treatment.</div></div><div><h3>Conclusion</h3><div>Spinal EBV-SMTs are rare CNS tumors to consider as differential diagnosis for immunocompromised patients with spine-related pain and/or neurological deficits. Neuroimaging for lesion detection followed by biopsy confirmation using specialized staining can confirm diagnosis. Multimodal treatment with efforts at optimizing immune competency, surgical resection, and emerging therapies such as mTOR inhibitors (sirolimus) and radiotherapy have been recommended. Our comprehensive review supports ongoing research efforts using multi-institutional databases to allow for enhanced scientific insights into these rare tumors.</div></div>","PeriodicalId":37134,"journal":{"name":"World Neurosurgery: X","volume":"29 ","pages":"Article 100553"},"PeriodicalIF":2.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145683122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}